Global Interferon Alpha-2a Biosimilar Market Survey and Trend Research 2018

September 2018 | 67 pages | ID: G0970D9E2D3EN
99Strategy

Abstracts

Summary

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Roche, Biosidus, Zydus Cadila, Nanogen, Rhein Minapharm Biogenetics, Rhein Minapharm Biogenetics, PROBIOMED, 3sbio etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Interferon Alpha-2a Biosimilar Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 INTERFERON ALPHA-2A BIOSIMILAR MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Roche (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Biosidus (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Zydus Cadila (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Nanogen (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Rhein Minapharm Biogenetics (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Rhein Minapharm Biogenetics (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 PROBIOMED (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 3sbio (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Interferon Alpha-2a Biosimilar Market 2012-2017, by Type, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market 2012-2017, by Type, in Volume
Table Global Interferon Alpha-2a Biosimilar Market Forecast 2018-2023, by Type, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market Forecast 2018-2023, by Type, in Volume
Table Roche Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biosidus Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Biosidus (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zydus Cadila Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Zydus Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nanogen Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Nanogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Rhein Minapharm Biogenetics Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Rhein Minapharm Biogenetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Rhein Minapharm Biogenetics Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of Rhein Minapharm Biogenetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PROBIOMED Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of PROBIOMED (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3sbio Overview List
Table Interferon Alpha-2a Biosimilar Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Interferon Alpha-2a Biosimilar Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Interferon Alpha-2a Biosimilar Sales Revenue Share, by Companies, in USD Million
Table Global Interferon Alpha-2a Biosimilar Sales Volume 2012-2017, by Companies, in Volume
Table Global Interferon Alpha-2a Biosimilar Sales Revenue Share, by Companies in 2017, in Volume
Table Interferon Alpha-2a Biosimilar Demand 2012-2017, by Application, in USD Million
Table Interferon Alpha-2a Biosimilar Demand 2012-2017, by Application, in Volume
Table Interferon Alpha-2a Biosimilar Demand Forecast 2018-2023, by Application, in USD Million
Table Interferon Alpha-2a Biosimilar Demand Forecast 2018-2023, by Application, in Volume
Table Global Interferon Alpha-2a Biosimilar Market 2012-2017, by Region, in USD Million
Table Global Interferon Alpha-2a Biosimilar Market 2012-2017, by Region, in Volume
Table Interferon Alpha-2a Biosimilar Market Forecast 2018-2023, by Region, in USD Million
Table Interferon Alpha-2a Biosimilar Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Interferon Alpha-2a Biosimilar Industry Chain Structure
Figure Global Interferon Alpha-2a Biosimilar Market Growth 2012-2017, by Type, in USD Million
Figure Global Interferon Alpha-2a Biosimilar Market Growth 2012-2017, by Type, in Volume
Figure Global Interferon Alpha-2a Biosimilar Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Interferon Alpha-2a Biosimilar Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region